Premium
Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance
Author(s) -
Afyon M.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13502
Subject(s) - cccdna , entecavir , medicine , hepatitis b virus , circular dna , virology , antiviral therapy , chronic hepatitis , virus , hepatitis b , immunology , biology , lamivudine , genetics , hbsag , genome , gene